BioRem (CVE:BRM) Trading Up 2.3% – Should You Buy?

Shares of BioRem Inc. (CVE:BRMGet Free Report) traded up 2.3% during trading on Wednesday . The stock traded as high as C$3.08 and last traded at C$3.08. 68,545 shares traded hands during mid-day trading, an increase of 126% from the average session volume of 30,386 shares. The stock had previously closed at C$3.01.

BioRem Stock Performance

The company has a quick ratio of 1.08, a current ratio of 1.57 and a debt-to-equity ratio of 48.97. The company has a 50 day simple moving average of C$2.65 and a 200-day simple moving average of C$2.30. The stock has a market capitalization of C$46.94 million, a price-to-earnings ratio of 14.19 and a beta of 0.85.

BioRem (CVE:BRMGet Free Report) last issued its quarterly earnings results on Monday, August 26th. The company reported C$0.02 earnings per share (EPS) for the quarter. BioRem had a return on equity of 59.68% and a net margin of 11.35%. The firm had revenue of C$7.30 million for the quarter.

About BioRem

(Get Free Report)

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.

Featured Articles

Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.